Compare · head to head
Frontline vs Santhera Pharmaceuticals
Frontline ranks higher overall — 360 rank 100 vs 29.
Frontline leads on Value (68 vs 43), Quality (77 vs 50), Growth (85 vs 63), Safety (71 vs 30) and Sentiment (49 vs 41).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Cyprus | Switzerland |
| Sector | Energy & Oil | Health Care |
| Industry | Oil, Gas & Consumable Fuels | Biotechnology |
| Size | Large | Small |
| ISIN | CY0200352116 | CH1276028821 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 100 | 29 |
| Value | 68 | 43 |
| Quality | 77 | 50 |
| Growth | 85 | 63 |
| Safety | 71 | 30 |
| Sentiment | 49 | 41 |
| Quality details | ||
| Profitability | 89 | 41 |
| Cash Truth | 64 | 59 |
Frontline vs FreightosFrontline vs Id LogisticsFrontline vs ZEAL NetworkFrontline vs XCHGAdd a third stock →
Full analyses: Frontline · Santhera Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100